Drug companies spend millions to keep charging high prices

August 26, 2016 10:03 AM

39 0

Pharmaceutical heavyweight Mylan, the latest poster child for drug-industry greed, finally stuck up for itself Thursday. It argued that “the system,” not avarice, was to blame for the company jacking up the price of EpiPens, a common (and life-saving) allergy remedy, by over 400%.

“Look, no one’s more frustrated than me,” Mylan Chief Executive Heather Bresch declared on CNBC.

Also read: University of Oklahoma president says $1B debt not uncommon

Read more

To category page